A B S T R A C T Bilirubin diglucuronide (BDG) may be formed in vitro by microsomal UDP glucuronosyl transferase (EC 2.4.1.17)-mediated transfer of a second mole of glucuronic acid from UDP-glucuronic acid, or by dismutation of bilirubin monoglucuronide (BMG) to BDG and unconjugated bilirubin, catalyzed by an enzyme (EC 2.4.1.95) that is concentrated in plasma membrane-enriched fractions of rat liver. To evaluate the role of these two enzymatic mechanisms in vivo, [3H]bilirubin mono-['4C]glucuronide was biosynthesized, purified by thin-layer chromatography, and tracer doses were infused intravenously in homozygous Gunn (UDP glucuronyl transferase-deficient) rats or Wistar rats. Bilirubin conjugates in bile were separated by high-pressure liquid chromatography and 3H and 14C were quantitated. In Gunn rats, the '4C:3H ratio in BDG excreted in bile was twice the ratio in injected BMG. In Wistar rats the '4C:3H ratio in biliary BDG was 1.25 ± 0.06(mean ± SEM)times the ratio in injected BMG. When double labeled BMG was injected in Wistar rats after injection of excess unlabeled unconjugated bilirubin (1.7 limol), the '4C:3H ratio in BDG excreted in bile was identical to the ratio in injected BMG. Analysis of isomeric composition of bilirubin conjugates after alkaline hydrolysis or alkaline methanolysis indicated that the bile pigments retained the IXa configuration during these experiments. The results indicate that both enzymatic dismutation and UDP glucuronyl transferase function in vivo in BDG formation, and that dismutation is inhibited by a high intrahepatic concentration of unconjugated bilirubin. This hypothesis was supported by infusion of [3H]bilirubin-monoglucuronide in isolated perfused homozygous Gunn rat liver after depletion of intrahepatic bilirubin by perfusion with bovine serum albumin (2.5%), and after bilirubin repletion following perfusion with 0.34 mM bilirubin. From 
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Cat (9) and rat (10) 
GENERAL METHODS
Preparation of [3H]bilirubin. Delta-amino levulinic acid-2,3-3H, 175 nmol (25 mCi) was injected intravenously into a dog that had a bile fistula (11) . Bile was collected in 4-h fractions with ascorbic acid as preservative. Conjugated bile pigments were subjected to alkaline hydrolysis; bilirubin was extracted and crystallized to constant specific activity (12) , and bilirubin IXa was purified by tlc (13 (16) . The organic phase was separated by centrifugation, reduced in volume in reduced pressure and applied to tlc plates (silicagel, 0.25 mm thick). Previously purified BMG and BDG were used as reference. Appropriate bands were scraped into centrifuge tubes; pigments were extracted in methanol, and silica gel was removed by centrifugation. (b) HPLC: Bile was mixed with an equal volume of methanol and centrifuged at 15,000 g X 3 min. The supernate (0.005 to 0.2 ml) was injected in a Waters' high pressure liquid chromatograph. The column was equilibrated with 50% methanol in sodium acetate buffer, 0.1 M, pH 4.0, containing 1-heptane sulfonic acid, 5 mM. The column was eluted with a concave gradient of methanol (50-100% in 60 min at a flow rate of 1 ml/min) in the above buffer. Elution was continued for 70 min. Absorption of eluate fractions at 436 nm-was determined, and peak areas were electronically integrated.
Identification of peaks: (a) Peaks were identified from comigration of biosynthesized BMG and BDG, which were purified by tlc. (b) Pigment peaks were mixed with an equal volume of ethyl anthranilate diazo reagent (17) . After 30 min at 25°C, methanol was evaporated in reduced pressure, and azodipyrroles were extracted in 1 ml methyl propyl ketone/butyl acetate (17:3, vol/vol) and quantitated after separation by tlc (17 Reproducibility of HPLC analysis: Normal rat bile, 0.5 ml was mixed with methanol, 0.5 ml and centrifuged (15, 000 g X 3 min). Samples from the supernatant (0.005, 0.025, 0.075, 0.1, and 0.15 ml) were chromatographed and BMG and BDG were quantitated from peak areas. A sample (0.05 ml) was injected five consecutive times and BMG and BDG were quantitated. Between injections, bile samples were stored at -70°C in the dark.
Radioactivity of the isolated pigment peaks: To decrease quenching and increased accuracy of counting, isolated bile pigments that were eluted from the HPLC column were exposed overnight to long wavelength ultraviolet light in sealed glass vials. This procedure bleached bile pigments and markedly decreased quenching. Aquasol (New England Nuclear), 15 ml, was added and 3H and "C were counted to 1% error, three times after storage in the dark for 16 h.
Quenching for 3H and 14C in each sample, cross-over of 3H counts into the '4C channel and cross-over of 14C counts into the 3H channel were calculated using internal standards. jumol bilirubin dissolved in 0.1 ml NaOH, 0.05 M, and diluted to 1 ml with rat serum). Bile was collected and pigments were analyzed by HPLC as described.
In each experiment, the last 0.1 ml of infusate was saved for analysis by HPLC and determination of radioactivity.
In two experiments, 0.1 ml of infusate was also mixed with 1 ml of Gunn rat bile and stored on ice for 2 h to evaluate degradation and dipyrrolic scrambling (18) of bile pigments during storage. Bile and infusate samples were stored in the dark in nitrogen at -70°C, and were analyzed within 6 h.
To evaluate the role of dipyrrolic scrambling (18) in the formation of BDG, 0.1 ml of perfusate and 0.1 ml of the bile after BMG infusion from two Wistar rat experiments were hydrolyzed in NaOH (1 M) that contained 0.4% ascorbic acid (18) . Unconjugated bilirubin was extracted in chloroform after acidification and mixed with bilirubin (Sigma Chemical Co.) in chloroform solution. Bilirubin isomers were separated by tlc (13); Illa, IX,, and XIII, bands were scraped, and radioactivity was determined. The isomeric configuration of bile pigments was further examined in the following experiments. Purified [3H]bilirubin tnonoglucuronide, 50-98 nmol, was dissolved in 0.1 M sodium phosphate buffer, pH 7.8, containing 4 mM sodium ascorbate, and 0.9 ml was injected within 2 min in two Gunn rats and one Wistar rat. Bile pigments in the last 0.1 ml of the infusate and in bile collected for 45 min after the infusion were analyzed by tlc after alkaline methanolysis as described by Blanckaert (19) . Bands representing bilirubin dimethylester and the four isomers of monomethylester (III., XIII,,, IX,, C-8, and C-12) were removed by scraping; radioactivity was determined after quench correction using an internal standard. To obtain reference methylesters, bilirubin IIIM, XIII, and IX. were produced by acid-catalyzed dipyrrolic disproportionation of commercial bilirubin (Sigma Chemical Co.) (20) . A mixture of the three isomers of bilirubin (2 mg) was dissolved in 0.25 ml of 0.01 N NaOH, diluted to 2 ml with sodium phosphate, 0.1 M, pH 7.8, and injected intravenously in a Wistar rat that was provided with a bile duct cannula. Bile was collected for 2 h, bilirubin conjugates were converted to methylesters by akaline methanolysis, and the dimethylester and monomethylester isomers were separated by tlc as described by Blanckaert (19) .
Infusion of 'H-bilirubin di-'4C-glucuronide in homozygous Gunn rats: Homozygous Gunn rats were prepared as described and infused with 20 
RESULTS
HPLC of normal Wistar rat bile revealed two major peaks (Fig. 1) . The pigment that comigrated with biosynthesized BMG yielded equal amounts of unconjugated (a) and glucuronidated (a) azodipyrroles on diazotization with diazo reagent (17 Fig. 1 . (See legend of Fig. 1.) 90% of injected "4C radioactivity were recovered in bile in 30 min. From 8 to 10% of injected 3H counts were in BDG. The '4C:3H ratio in injected BMG was equal to the 14C:3H ratio in BMG excreted in bile, and was half the '4C:3H ratio in BDG excreted in bile (Table I) . These results indicate that the second mole of glucuronic acid in BDG excreted in bile is derived from the injected double-labeled BMG.
Infusion of [3H]bilirubin mono-[14C]glucuronide in
Wistar rats (Table I) . From 80 to 90% of injected 3H radioactivity and 80 to 84% of injected 14C radioactivity were recovered in bile in 30 min. From 27 to 30% of injected 3H radioactivity was in BDG. The '4C:3H ratio in BDG excreted in bile was 20-30% greater than the 14C:3H ratio in injected BMG and 40-50% greater than the ratio in BMG excreted in bile. When double-labeled BMG was subsequently injected with 1.7 umol unconjugated bilirubin in two of these rats, the 14C:3H ratio in BDG excreted in bile was 99.5%, which was approximately equal to the ratio in injected BMG and in BMG that was excreted in bile.
Isomeric configuration of bilirubin in the conjugates excreted in bile. (a) Alkaline hydrolysis: In the infused BMG, 99.5% of 3H radioactivity was in the IXa isomer. In bile from two Wistar rats after infusion of BMG, 98.9 and 99.4% of 3H radioactivity was in the IXa band. (b) Alkaline methanolysis: Alkaline methanolysis of the injected bilirubin monoglucuronide preparation yielded -2% dimethylester (Table II) . In two Gunn rats, 8-10% of methylesters produced by alkaline methanolysis of bilirubin conjugates excreted in bile after infusion of [3H]bilirubin monoglucuronide was bilirubin dimethylester. There was no significant difference in the isomeric composition of bilirubin monomethylesters between the injected material and that excreted in bile (Table II) . After injection of labeled monoglucuronide in a Wistar rat and alkaline methanolysis of pigments excreted in bile, 30% of radioactivity in bile was found in the dimethylester. Again, there was no change in the isomeric composition of the monomethylester (Table II) .
Infusion of [3H]bilirubin di-['4C
]glucuronide in homozygous Gunn rats (Table III) . After infusion of double-labeled BDG, 90% of 3H radioactivity and 82-85% of 14C radioactivity were recovered in bile in 30 min. From 5 to 7% of injected 3H radioactivity was in BMG. The '4C:3H ratio in BDG excreted in bile was only 10% greater than the ratio in BMG excreted in bile.
Experiments in isolated perfused homozygous Gunn rat liver (Table IV) . Unconjugated bilirubin concentrations in the liver of two control Gunn rats were 51 and 48 nmol/g wet weight of liver, respectively. In two Gunn rats from the same litter, after 30 min perfusion with an albumin-containing perfusate, the hepatic unconjugated bilirubin concentrations were 15 [3H]bilirubin mono{'4Clglucuronide was biosynthesized, purified by tlc, dissolved in 1.0 ml rat serum and injected intravenously. Bile was collected for 30 min, pigments were separated by tlc or HPLC (see Methods) and 3H and '4C were quantitated. The data shown are after correction for quench and crossover of 3H counts into "4C channel and vice versa. The data represent individual experiments. In Wistar rats 4 and 5, the double-labeled pigment was injected once alone (A) and once after the injection of 1.7 umol unconjugated bilirubin (B).
rated bilirubin methylesters following alkaline meth-arates the different sugar conjugates, and permits anolysis of bilirubin conjugates (19) . The method re-study of the metabolic fate of the sugar moiety. ported here is accurate, reproducible, highly sensitive Pure BMG and BDG standards are not available. and adaptable to radioassay. In contrast to the alkaline To circumvent this problem, we biosynthesized methanolysis method, the present method does not [8H]bilirubin mono-and diglucuronide from radiorequire replacement of the conjugating moiety, sep-chemically pure [3H]bilirubin IX,. Thus, pigments sep- 
See text for experimental details. The data are results of individual experiments. DME, bilirubin dimethylester; MME, bilirubin monomethylester; UCB, unconjugated bilirubin. [3H]bilirubin di-l4C]glucuronide was biosynthesized and purified by tlc as described in Methods. The pigment was dissolved in 1 ml rat serum and injected intravenously. Bile was collected for 30 min, pigments were separated by HPLC, and 3H and "4C were quantitated. The data represent individual experiments.
arated by HPLC could be quantitated from radioactivity, and nanomoles per unit area under the chromatographic peaks would be determined.
]glucuronide was infused in homozygous Gunn rats, it was partly converted to BDG. This confirms our previous observations (8) . Because Gunn rats lack UDP-glucuronate glucuronyl transferase activity, conversion of BMG cannot be due to transfer of a glucuronic acid moiety from UDP glucuronic acid. The 14C:3H ratio in BDG excreted in bile was double the ratio in injected BMG indicating that the second glucuronyl group is entirely derived by dismutation from injected labeled BMG.
When double-labeled BMG was infused in normal rats, the "4C:3H ratio in BDG in bile was greater than, but less than double, the ratio in injected BMG (7) . However, the present study indicates that both glucuronyl transferase and dismutation of BMG function in vivo to convert BMG to BDG. BMG can also be converted to BDG by nonenzymatic dipyrrolic disproportionation in vitro (18, 25) . In this free radical reaction, symmetrical bilirubin isomers, IIIa and XIIIa, are formed (18, 25) .
Since bilirubin in bile is almost exclusively IXa, dipyrrolic scrambling is not important in BDG formation in vivo. In the present study, we searched for nonenzymatic dipyrrolic disproportionation by alkaline hydrolyis and alkaline methanolysis of bilirubin conjugates in the infusate and in the conjugates excreted in bile. Alkaline hydrolysis of the last 0.1 ml of the infused bilirubin monoglucuronide preparation and of bilirubin conjugates excreted in Wistar rat bile after infusion of the labeled BMG indicated negligible formation of lIla and XIIIa isomers. In other experiments, random dipyrrolic scrambling during infusion was prevented by addition of 4 mM ascorbate (25) in the infusate. Alkaline methanolysis of conjugated bilirubin excreted in bile after infusion of labeled BMG in two Gunn rats and one Wistar rat showed BDG formation without appreciable change in the isomeric composition of BMG. The results indicate that conversion of BMG to BDG cannot be explained by random nonenzymatic dipyrrolic disproportionation.
To study the participation of other glucuronides in the enzymatic conversion of BMG to BDG, p-nitrophenol glucuronide or phenolphthalein glucuronide were incubated with BMG and a rat liver plasma membrane fraction (15) in presence of a f3-glucuronidase inhibitor, glucaro-1,4-lactone. Conversion of BMG to BDG was not associated with formation of unconjugated p-nitrophenol or phenolphthalein; BMG is the only known substrate for the dismutating enzyme.
The mechanism of inhibition of dismutation by high intrahepatic unconjugated bilirubin concentration is not known. Reversal of the dismutation reaction (i.e., conversion unconjugated bilirubin and BDG to BMG) is a possible mechanism. Such 
